Latest Articles

Publication Date
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView

ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView

Published: Feb. 27, 2026, 2:50 p.m.
dtic Backs Probe into Sanitary Pad Safety Concerns - Devdiscourse

dtic Backs Probe into Sanitary Pad Safety Concerns Devdiscourse

Published: Feb. 27, 2026, 1:17 p.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus

Published: Feb. 27, 2026, 7:22 a.m.
Probe into Sanitary Pad Brands Over Chemical Safety Concerns - Jacaranda FM

Probe into Sanitary Pad Brands Over Chemical Safety Concerns Jacaranda FM

Published: Feb. 25, 2026, 7:09 a.m.
UGA Forest Education Center to host annual fire safety festival in Guyton - WTOC

UGA Forest Education Center to host annual fire safety festival in Guyton WTOC

Published: Feb. 18, 2026, 4:34 p.m.
The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.

Letrozole and other aromatase inhibitors are increasingly recognized as first-line ovulation induction (OI) medications, offering an efficient and physiologic approach to ovarian stimulation that enhances outcomes in reproductive medicine. By …

Published: Feb. 17, 2026, midnight
Indocyanine green in intestinal endometriosis surgery: a multicenter evaluation of anastomotic safety.

To evaluate whether the use of intraoperative indocyanine green (ICG) fluorescence impacts anastomotic safety and surgical outcomes in patients undergoing bowel endometriosis resection.

Published: Feb. 16, 2026, midnight
Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach.

Endometriosis is a complex, estrogen-dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, …

Published: Feb. 13, 2026, midnight
From Pelvis to Groin: Non-Communicating Rudimentary Uterine Horn and Endometriosis Presenting as an Inguinal Hernia in a Woman with a Solitary Pelvic Kidney.

Müllerian anomalies complicated by extrapelvic endometriosis are uncommon, and herniation of Müllerian remnants into the inguinal canal is exceptionally rare. These complex presentations pose significant diagnostic challenges arising from intricate …

Published: Feb. 11, 2026, midnight
Reply of the Authors: Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.

Published: Feb. 10, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!